Loading...
Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone
PPARγ regulates both glucose metabolism and bone mass. Recent evidence suggests that the therapeutic modulation of PPARγ activity with anti-diabetic thiazolidinediones elicits unwanted effects on bone. In this study, the effects of rosiglitazone on the skeleton of growing (1 month), adult (6 month),...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2007
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2084459/ https://ncbi.nlm.nih.gov/pubmed/17332064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2006-1587 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|